HCA Holdings’s Overweight Rating Reaffirmed at JPMorgan Chase & Co. (HCA)
HCA Holdings (NYSE:HCA)‘s stock had its “overweight” rating restated by equities researchers at JPMorgan Chase & Co. in a research report issued on Tuesday. They currently have a $60.00 price target on the stock, up from their previous price target of $58.00. JPMorgan Chase & Co.’s price target would suggest a potential upside of 13.23% from the stock’s previous close.
HCA Holdings (NYSE:HCA) traded up 2.07% on Tuesday, hitting $54.085. 1,279,732 shares of the company’s stock traded hands. HCA Holdings has a 52 week low of $35.20 and a 52 week high of $54.00. The stock has a 50-day moving average of $51.60 and a 200-day moving average of $49.43. The company has a market cap of $24.047 billion and a price-to-earnings ratio of 15.63.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.84 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.85 by $0.01. The company had revenue of $9.68 billion for the quarter, compared to the consensus estimate of $8.90 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Analysts expect that HCA Holdings will post $3.70 EPS for the current fiscal year.
In other HCA Holdings news, major shareholder Henry R. Kravis sold 14,777,314 shares of HCA Holdings stock in a transaction that occurred on Friday, May 23rd. The stock was sold at an average price of $51.53, for a total value of $761,474,990.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Other equities research analysts have also recently issued reports about the stock. Analysts at Mizuho raised their price target on shares of HCA Holdings from $57.00 to $60.00 in a research note on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Oppenheimer raised their price target on shares of HCA Holdings from $55.00 to $62.00 in a research note on Wednesday, April 30th. They now have an “outperform” rating on the stock. Three investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $55.50.
HCA Holdings, Inc (NYSE:HCA) is a holding company whose affiliates owns and operates hospitals and related health care entities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.